Clinical Trials

Phase 2 Active not recruiting

Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms

NCT03951831 2025-04-25

REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

26 enrolled

Neoplasms, Prostatic Neoplasms

NCT00446225 2025-03-05

EURTAC

174 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03837977 2024-12-30

NET02

Phase 3 Active not recruiting

58 enrolled

Endocrine

Neoplasms, Carcinoma, Neuroendocrine

NCT00798070 2024-12-18

PANTHER

2,017 enrolled

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasms

NCT01957436 2024-11-12

PEACE1

1,173 enrolled

Neoplasms, Prostatic Neoplasms

NCT00587431 2023-11-07

Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer

102 enrolled 8 charts

Neoplasms, Prostatic Neoplasms

NCT02126969 2023-03-13

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

45 enrolled 13 charts

Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

NCT03402048 2020-11-04

EPIC

Phase 3 Unknown

567 enrolled

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT00206518 2020-07-28

TACAC

167 enrolled 10 charts

Breast Neoplasms, Neoplasms

NCT02403531 2020-06-02

Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

110 enrolled

Esophageal Neoplasms, Neoplasms

NCT01869192 2019-09-24

Phase II Trial for Large ER-Negative Breast Cancers

72 enrolled 6 charts

Neoplasms

NCT02900742 2019-04-12

Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer

71 enrolled

Lung Neoplasms, Neoplasms

NCT00979641 2019-03-28

AINO

65 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01888978 2018-04-09

Molecularly Tailored Therapy for Pancreas Cancer

19 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00201812 2017-12-06

Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors

27 enrolled

Neoplasms

NCT02474186 2017-08-03

Phase II Study for Solid Metastatic Tumors

41 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00226239 2017-07-11

Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer

39 enrolled 10 charts

Neoplasms

NCT00591149 2017-06-14

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

16 enrolled 5 charts

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT00741195 2016-10-04

Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer

50 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00659269 2016-02-26

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

319 enrolled 7 charts

Neoplasms, Neuralgia

NCT00177255 2016-02-08

A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

40 enrolled 6 charts

Neoplasms

NCT01685489 2015-10-27

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

Phase 1 Withdrawn

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT00755157 2015-10-07

Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer

Phase 2 Withdrawn

Neoplasms, Small Cell Lung Carcinoma

NCT00758732 2015-09-28

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

34 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT01754623 2015-08-13

GTX-RT in Borderline Resectable Pancreatic Cancer

9 enrolled 7 charts

Neoplasms, Pancreatic Neoplasms

NCT00660699 2015-05-27

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

50 enrolled 21 charts

Gallbladder Neoplasms, Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT01611961 2014-09-30

Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients

Phase 1 Unknown

35 enrolled

Neoplasms

NCT00183742 2014-05-22

Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)

35 enrolled

Carcinoma, Neoplasms

NCT00418704 2013-10-01

Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Completed

100 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT01338753 2013-09-10

IMAGING

74 enrolled

Breast Neoplasms, Neoplasms

NCT00206453 2013-02-05

Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer

25 enrolled

Breast Neoplasms, Neoplasms

NCT00442026 2012-06-27

Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC

Phase 3 Terminated

106 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00453635 2012-03-13

Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

88 enrolled

Breast Neoplasms, Neoplasms

NCT00206466 2012-01-25

TAX/AC

70 enrolled

Breast Neoplasms, Neoplasms

NCT01083589 2012-01-11

Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)

22 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00206505 2011-11-17

Neoadjuvant Taxotere

40 enrolled

Breast Neoplasms, Neoplasms

NCT00232206 2011-05-18

Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT00049296 2010-06-11

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

26 enrolled

AIDS-related Kaposi sarcoma, Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Appendiceal Neoplasms, Astrocytoma, Bile Duct Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Chondrosarcoma, Colonic Neoplasms, Craniopharyngioma, Ependymoma, Esophageal Neoplasms, Gallbladder Neoplasms, Glioblastoma, Glioma, Carcinoma, Hepatocellular, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Medulloblastoma, Melanoma, Meningioma, Multiple Myeloma, Neoplasms, Neuroblastoma, Oligodendroglioma, Pancreatic Neoplasms, Pinealoma, Rectal Neoplasms, Salivary Gland Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Stomach Neoplasms, Urethral Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal Tumors, Primitive, Esthesioneuroblastoma, Olfactory, Glioma, Subependymal, Gliosarcoma, Lymphoma, B-Cell, Marginal Zone, Breast Neoplasms, Male, Lymphoma, Mantle-Cell, Gastrointestinal Stromal Tumors, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Small Cell Lung Carcinoma

NCT00845884 2009-02-18

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

Phase 1/2 Unknown

49 enrolled

Neoplasms

NCT00193570 2009-01-23

Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors

20 enrolled

Neoplasms

NCT00441922 2008-10-29

Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

166 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00415285 2007-02-13

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Phase 2 Unknown

100 enrolled